Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103+DCs‐mediated CD8+T cell responses
Fuping Zhang, Chengshi Wang, Xin Wen, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 10, pp. 5817-5831
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Lucas Opazo-Ríos, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3798-3798
Open Access | Times Cited: 223
Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
Luise Müller, Antje Tunger, Manja Wobus, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 127
Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
Jiahao Chen, Qinhui Liu, Jinhan He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 96
T cells and their products in diabetic kidney disease
Yue Liu, Yaodong Lv, Tingwei Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
Mengtian Guo, Zhenyu Yin, Fanglian Chen, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 133
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al‐Gazally, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway
Nesrine Ebrahim, Hajer A. Al Saihati, Zahraa Alali, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116836-116836
Open Access | Times Cited: 15
The therapeutic effect of mesenchymal stem cells in diabetic kidney disease
Umm E. Habiba, Nasar Khan, David Lawrence Greene, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 4, pp. 537-570
Open Access | Times Cited: 11
Therapeutic potential: The role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy
Lixin Liu, Yiman Chen, Xuan Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116672-116672
Open Access | Times Cited: 9
Novel ferroptosis gene biomarkers and immune infiltration profiles in diabetic kidney disease via bioinformatics
Yixiong Huang, Xinke Yuan
The FASEB Journal (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 7
TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases
Philip Chiu‐Tsun Tang, Alex Chan, Cai-Bin Zhang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 40
Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging
Peng Yan, Ben Ke, Xiangdong Fang
Heliyon (2024) Vol. 10, Iss. 2, pp. e24872-e24872
Open Access | Times Cited: 4
Pathological mechanism of immune disorders in diabetic kidney disease and intervention strategies
Tong Zhou, Yilin Fang, Tiantian Tian, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 6, pp. 1111-1121
Open Access | Times Cited: 4
Cuproptosis gene characterizes the immune microenvironment of diabetic nephropathy
Liping Guo, Liu Fei, Hui Li, et al.
Transplant Immunology (2025), pp. 102175-102175
Closed Access
New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy
Canyu Chen, Bo Xu, Weiyi Li, et al.
European Journal of Pharmacology (2025), pp. 177543-177543
Closed Access
Bone Marrow Mesenchymal Stem Cells Ameliorate Cisplatin-Induced Renal Fibrosis via miR-146a-5p/Tfdp2 Axis in Renal Tubular Epithelial Cells
Lei Wu, Chao Rong, Qing Zhou, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 26
Metabolic signatures of immune cells in chronic kidney disease
Jie Li, Yi Yang, Yanan Wang, et al.
Expert Reviews in Molecular Medicine (2022) Vol. 24
Open Access | Times Cited: 18
Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy
Huandi Zhou, Lin Mu, Zhifen Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Human placenta‐derived mesenchymal stem cells ameliorate diabetic kidney disease by modulating the T helper 17 cell/ regulatory T‐cell balance through the programmed death 1 / programmed death‐ligand 1 pathway
Jiao Wang, Honghong Liu, Guanru Yue, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 1, pp. 32-45
Closed Access | Times Cited: 9
Identification of potential key lipid metabolism-related genes involved in tubular injury in diabetic kidney disease by bioinformatics analysis
Yuanshuo Fan, Juan He, Lixin Shi, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 8, pp. 1053-1068
Closed Access | Times Cited: 3
Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy
Yan Wu, Chunlei Zhang, Ran Guo, et al.
Stem Cells International (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 22
Role of Dendritic Cell in Diabetic Nephropathy
Hyunwoo Kim, Mi‐Yeon Kim, Hwa Young Lee, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7554-7554
Open Access | Times Cited: 22
Integrated Analysis of Single-Cell RNA-Seq and Bulk RNA-Seq Combined with Multiple Machine Learning Identified a Novel Immune Signature in Diabetic Nephropathy
Yue-Ling Peng, Yan Zhang, Lin Pang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1669-1684
Open Access | Times Cited: 7
Causal effect of gut microbiota and diabetic nephropathy: a Mendelian randomization study
Ganyuan He, Jiayi Chen, Wenke Hao, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives
Zhongyu Han, Kuai Ma, Hongxia Tao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top